Ontology highlight
ABSTRACT: Aims/introduction
To establish novel therapies to combat diabetic kidney disease, a human disease-relevant animal model is essential. However, a type 2 diabetic mouse model presenting progressive kidney fibrosis has not yet been established. Kidneys of streptozotocin-induced diabetic CD-1 mice showed severe fibrosis compared with other backgrounds of mice associated with the suppression of antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline. The BKS background (BKSdb / db ) is often utilized for diabetic kidney disease research; the kidney fibrosis in the BKSdb / db phenotype is minimal.Materials and methods
We generated CD-1db / db mice by backcrossing the db gene into
SUBMITTER: Mizunuma Y
PROVIDER: S-EPMC7610117 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature